Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

roche.com

Investor Update

Get the latest updates from Investor Update directly as they happen.

Follow now 351 followers

Latest posts

Last updated 27 days ago

Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)

27 days ago

Susvimo is the only continuous delivery treatment to provide reliable, long-term vision...

Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC

about 1 month ago

Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust...

Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU

about 1 month ago

EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for...

Invitation to Roche’s Pharma Day 2025

about 1 month ago

The Roche Investor Relations team would like to invite you to the...

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s disease

about 1 month ago

Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test...

European Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation

about 1 month ago

Approval based on INAVO120 data showing the Itovebi™ (inavolisib)-based regimen more than...

Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

about 1 month ago

Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will...

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary disease

about 1 month ago

The pivotal phase IIb ALIENTO study met the primary endpoint of a...

Reminder: Invitation to Roche’s Half Year Results 2025 Presentation

about 1 month ago

  Roche will publish its Half Year Results of 2025 prior to the...

Invitation to Roche’s Half Year Results 2025 Presentation

2 months ago

  Roche will publish its Half Year Results of 2025 prior to the...